Middle East & Africa Cardiac Monitoring Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Cardiovascular Devices, Multi-Parameter ECG Monitors, Patient Monitoring Devices, Ambulatory Cardiac Monitoring, and Cardiac Monitors), Product Type (Portable Monitor, Smart Wearable Monitor, and Standard Monitor), Application [Coronary Heart Diseases, Sudden Cardiac Arrest, Stroke, Arrhythmia, Congenital Heart Diseases, Heart Failure, Pulmonary Hypertension, Heart Function (HF/LVEDP), Pulmonary Artery Pressure (PA), and Others], and End User (Hospitals, Ambulatory Surgery Centers, Cardiac Centers, Home Care, Clinics, and Others)

The cardiac monitoring devices market in the MEA is expected to grow from US$ 1,206.46 million in 2021 to US$ 1,727.96 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028.

Changes or shifts in technology-related trends encourage players to develop innovative devices. Recent developments in HIPPA-compliant technology have enabled secured data transmission throughout the monitoring period without delays. Emerging technologies are providing effective alternatives for traditional treatments that create alerts for patients with a high risk of cardiovascular disease. Hence, continuous remote monitoring capabilities of cardiac monitors, facilitating long-term, uninterrupted cardiac rhythm management, are adding to their popularity. The mobile cardiac telemetry (MCT) system is an innovative product that assists in monitoring the heart conditions of cardiac patients. Patients carry the tiny sensor and monitor throughout the day, and whenever a cardiac event occurs, the MCT sends the data to a central system for analysis and response. The system generates a report, along with graphs and trends, and shares it with the patient's physicians for further actions. The ability of MCT systems to analyze every heartbeat and detect slight irregularities in a patient's normal conditions, followed by initiating an immediate emergency response, makes them one of the most attractive choices for cardiac monitoring. Thus, a rise in the number of product developments, launches, and approvals would emerge as a new trend in the cardiac monitoring devices market during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA cardiac monitoring devices market in the coming years. The market is expected to grow at a good CAGR during the forecast period.

MEA Cardiac Monitoring Devices Market Revenue and Forecast to 2028 (US$ Million)

MEA Cardiac Monitoring Devices Market Segmentation

The MEA cardiac monitoring devices market is segmented on the basis of type, product type, application, end user, and country. Based on type, the market is segmented into cardiovascular devices, multi-parameter ECG monitors, patient monitoring devices, ambulatory cardiac monitoring, and cardiac monitors. In 2020, the cardiovascular devices segment held the largest share of the market. Based on product type, the MEA cardiac monitoring devices market is segmented into portable monitor, smart wearable monitor, and standard monitor. In 2020, the standard monitor segment held the largest share of the market. Based on application, the market is segmented into coronary heart diseases, sudden cardiac arrest, stroke, arrhythmia, congenital heart diseases, heart failure, pulmonary hypertension, heart function (HF/LVEDP), pulmonary artery pressure (PA), and others. The coronary heart diseases segment held the largest market share in 2020 and is expected to be the largest shareholder in the market by 2028. Based on end user, the MEA cardiac monitoring devices market is segmented into hospitals, ambulatory surgery centers (ASCs), and clinics. The hospitals segment held the largest market share in 2020. Based on country, the MEA cardiac monitoring devices market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Abbott; AliveCor, Inc; Amiitalia; Asahi Kasei Corporation; Biotronik, Inc.; Boston Scientific Corporation; BTL; GE Healthcare; Hill-Rom Holdings, Inc.; Infinium Medical; Koninklijke Philips N.V.; LivaNova PLC; Medtronic; Nihon Kohden Corporation; SCHILLER Healthcare India Pvt. Ltd; and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. are among the leading companies in the MEA cardiac monitoring devices market.

1. Abbott
2. Amiitalia
3. Asahi Kasei Corporation
4. Biotronik, Inc.
5. Boston Scientific Corporation
6. BTL
7. GE Healthcare
8. Hill-Rom Holdings, Inc.
9. Infinium Medical
10. Koninklijke Philips N.V.
11. LivaNova PLC
12. Medtronic
13. Nihon Kohden Corporation
14. SCHILLER Healthcare India Pvt. Ltd
15. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA cardiac monitoring devices market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the MEA cardiac monitoring devices market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the cardiac monitoring devices market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution